tiprankstipranks
Advertisement
Advertisement

IMMX Stock Latest News

Midday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis
The FlyMidday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis
1d ago
BA
DX
Immix Biopharma announces termination of CMO Richard Graydon
PremiumThe Fly
Immix Biopharma announces termination of CMO Richard Graydon
1d ago
IMMX
Wanted fugitive secretly working at Immix as CMO, STAT reports
PremiumThe Fly
Wanted fugitive secretly working at Immix as CMO, STAT reports
1d ago
IMMX
Immix Biopharma Announces Leadership Change With Minimal Impact
PremiumCompany Announcements
Immix Biopharma Announces Leadership Change With Minimal Impact
1d ago
8K
IMMX
Immix Biopharma initiated with a Buy at BofA
PremiumThe Fly
Immix Biopharma initiated with a Buy at BofA
1M ago
IMMX
Immix Biopharma initiated with an Outperform at LifeSci Capital
PremiumThe FlyImmix Biopharma initiated with an Outperform at LifeSci Capital
1M ago
IMMX
Immix Biopharma Shareholders Back Board and Auditor at AGM
Premium
Company Announcements
Immix Biopharma Shareholders Back Board and Auditor at AGM
2M ago
8K
IMMX
Immix Biopharma price target raised to $20 from $15 at H.C. Wainwright
Premium
The Fly
Immix Biopharma price target raised to $20 from $15 at H.C. Wainwright
2M ago
IMMX
Immix Biopharma Raises $150 Million to Advance NXC-201
PremiumCompany Announcements
Immix Biopharma Raises $150 Million to Advance NXC-201
2M ago
8K
IMMX
Immix Biopharma Reports Strong Interim NXC-201 Phase 2 Data
PremiumCompany Announcements
Immix Biopharma Reports Strong Interim NXC-201 Phase 2 Data
2M ago
8K
IMMX
Immix Biopharma’s NXC-201 reaches 95% complete response rate in AL amyloidosis
PremiumThe Fly
Immix Biopharma’s NXC-201 reaches 95% complete response rate in AL amyloidosis
2M ago
IMMX
Citizens biotechnology analyst holds analyst/industry conference call
PremiumThe Fly
Citizens biotechnology analyst holds analyst/industry conference call
3M ago
AZ
GSK
Immix Biopharma Completes NEXICART-2 Enrollment for NXC-201
PremiumCompany AnnouncementsImmix Biopharma Completes NEXICART-2 Enrollment for NXC-201
4M ago
8K
IMMX
Immix Biopharma completes NEXICART-2 enrollment, onboards CMO Richard Graydon
Premium
The Fly
Immix Biopharma completes NEXICART-2 enrollment, onboards CMO Richard Graydon
4M ago
MRK
IMMX
Immix Biopharma price target raised to $15 from $14 at Mizuho
Premium
The Fly
Immix Biopharma price target raised to $15 from $14 at Mizuho
4M ago
IMMX
Immix Biopharma price target raised to $15 from $12 at H.C. Wainwright
PremiumThe Fly
Immix Biopharma price target raised to $15 from $12 at H.C. Wainwright
4M ago
IMMX
Immix Biopharma Amends ATM Offering to Raise Capital
PremiumCompany Announcements
Immix Biopharma Amends ATM Offering to Raise Capital
4M ago
8K
IMMX
Immix Biopharma initiated with an Overweight at Morgan Stanley
PremiumThe Fly
Immix Biopharma initiated with an Overweight at Morgan Stanley
4M ago
IMMX
Immix Biopharma initiated with an Outperform at Citizens
PremiumThe Fly
Immix Biopharma initiated with an Outperform at Citizens
4M ago
IMMX
Immix Biopharma initiated with an Outperform at Mizuho
PremiumThe FlyImmix Biopharma initiated with an Outperform at Mizuho
5M ago
IMMX
Immix Biopharma receives FDA breakthrough therapy designation for NXC-201
Premium
The Fly
Immix Biopharma receives FDA breakthrough therapy designation for NXC-201
6M ago
IMMX
Immix Biopharma files $750M mixed securities shelf
Premium
The Fly
Immix Biopharma files $750M mixed securities shelf
6M ago
IMMX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >